Sacituzumab Govitecan in Recurrent Glioblastoma
Clinical trial NCT04559230 · RECRUITING
Trial details
- NCT number
- NCT04559230
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-06
- Primary completion
- 2027-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.